{"transactions":[{"id":777112,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":46910,"kind":"person","name":"Paulson Richard A.","position":1,"cik":"0001804460","reported_name":"Paulson Richard A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-05-15T20:03:58.000Z","date":"2026-05-14","kind":"sale","planned":false,"acquired":false,"shares":2203,"price":9.5,"value":20928.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a durable automatic sale instruction plan adopted by the reporting person on June 10, 2021, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of PSUs. The sale does not represent a discretionary trade by the reporting person."}],"balance_after":269747,"source":{"system":"sec-edgar","filing":"0001193125-26-226613","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1804460/000119312526226613/ownership.xml","form_type":"4"}},{"id":777111,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":46910,"kind":"person","name":"Paulson Richard A.","position":1,"cik":"0001804460","reported_name":"Paulson Richard A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-05-15T20:03:58.000Z","date":"2026-05-13","kind":"grant","planned":false,"acquired":true,"shares":4920,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of the issuer's common stock underlying performance-based restricted stock units (\"PSUs\") granted in February 2024 that have been earned based on the level of achievement of the clinical milestone for complete enrollment in the Company's Phase 3 XPORT-EC-042 trial, as certified by the issuer's Compensation Committee on May 13, 2026. Each earned PSU represents the contingent right to receive one share of the issuer's common stock upon vesting. The earned PSUs vested on May 13, 2026."}],"balance_after":271950,"source":{"system":"sec-edgar","filing":"0001193125-26-226613","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804460/000119312526226613/ownership.xml","form_type":"4"}},{"id":867782,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":46910,"kind":"person","name":"Paulson Richard A.","position":1,"cik":"0001804460","reported_name":"Paulson Richard A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-03-03T21:21:19.000Z","date":"2026-03-02","kind":"sale","planned":false,"acquired":false,"shares":12361,"price":9.4095,"value":116310.8295,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a durable automatic sale instruction plan adopted by the reporting person on June 10, 2021, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units. The sale does not represent a discretionary trade by the reporting person."}],"balance_after":267030,"source":{"system":"sec-edgar","filing":"0001804460-26-000003","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804460/000180446026000003/ownership.xml","form_type":"4"}},{"id":914533,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":46910,"kind":"person","name":"Paulson Richard A.","position":1,"cik":"0001804460","reported_name":"Paulson Richard A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-02-09T21:11:58.000Z","date":"2026-02-05","kind":"grant","planned":false,"acquired":true,"shares":81060,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the award of restricted stock units (\"RSUs\") pursuant to the Karyopharm Therapeutics Inc. 2022 Equity Incentive Plan, as amended. RSUs convert into Karyopharm Therapeutics Inc. common stock on a one-for-one basis. The RSUs vest as to 50% of the shares on January 31, 2027, with the remaining 50% vesting on January 31, 2028."}],"balance_after":279391,"source":{"system":"sec-edgar","filing":"0001193125-26-042799","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804460/000119312526042799/ownership.xml","form_type":"4"}},{"id":1017626,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":46910,"kind":"person","name":"Paulson Richard A.","position":1,"cik":"0001804460","reported_name":"Paulson Richard A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-10-16T20:29:37.000Z","date":"2025-10-15","kind":"grant","planned":false,"acquired":true,"shares":114285,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the award of restricted stock units (\"RSUs\") pursuant to the Karyopharm Therapeutics Inc. 2022 Equity Incentive Plan, as amended. RSUs convert into Karyopharm Therapeutics Inc. common stock on a one-for-one basis. The RSUs vest 100% on December 31, 2026."}],"balance_after":198331,"source":{"system":"sec-edgar","filing":"0001193125-25-241471","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804460/000119312525241471/ownership.xml","form_type":"4"}},{"id":1039394,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":46910,"kind":"person","name":"Paulson Richard A.","position":1,"cik":"0001804460","reported_name":"Paulson Richard A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-09-16T20:35:49.000Z","date":"2025-09-15","kind":"sale","planned":false,"acquired":false,"shares":1257,"price":6.43,"value":8082.51,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a durable automatic sale instruction plan adopted by the reporting person on  June 10, 2021, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of PSUs. The sale does not represent a discretionary trade by the reporting person."}],"balance_after":84046,"source":{"system":"sec-edgar","filing":"0001193125-25-205052","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1804460/000119312525205052/ownership.xml","form_type":"4"}},{"id":1039393,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":46910,"kind":"person","name":"Paulson Richard A.","position":1,"cik":"0001804460","reported_name":"Paulson Richard A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-09-16T20:35:49.000Z","date":"2025-09-12","kind":"grant","planned":false,"acquired":true,"shares":2800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of the issuer's common stock underlying performance-based restricted stock units (\"PSUs\") granted in February 2023 that have been earned based on the level of achievement of the clinical milestone for complete enrollment in the Company's Phase 3 SENTRY trial, as certified by the issuer's Compensation Committee on September 12, 2025. Each earned PSU represents the contingent right to receive one share of the issuer's common stock upon vesting. The earned PSUs vested on September 12, 2025."}],"balance_after":85303,"source":{"system":"sec-edgar","filing":"0001193125-25-205052","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804460/000119312525205052/ownership.xml","form_type":"4"}},{"id":1125176,"issuer":{"id":78923,"kind":"organization","name":"bluebird bio, Inc.","symbol":"BLUE"},"owners":[{"id":46910,"kind":"person","name":"Paulson Richard A.","position":1,"cik":"0001804460","reported_name":"Paulson Richard A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-03T21:14:16.000Z","date":"2025-06-02","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1323,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each time-based restricted stock unit award with respect to shares that is, at the time of determination, subject to vesting or forfeiture conditions and that is not a PSU Award (as defined below) (but including, for clarity, any PSU Award that is subject solely to service-based vesting conditions as of the Effective Time) (\"RSU Award\") that is outstanding as of immediately prior thereto, shall (a) accelerate and become fully vested, and (b) by virtue of the Merger automatically (except as otherwise provided in the Merger Agreement) and without any action on the part of the Issuer, Parent or the holder thereof, be canceled and terminated and converted into the right to receive"},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"(Continued from footnote 3) (i) an amount in cash equal to the product of the number of shares underlying such RSU Award immediately prior to the Effective Time and $3.00 in cash, subject to any applicable withholding taxes and without interest thereon plus (ii) one CVR with respect to each share subject to such RSU Award immediately prior to the Effective Time."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950170-25-081108","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1804460/000095017025081108/ownership.xml","form_type":"4"}},{"id":1125175,"issuer":{"id":78923,"kind":"organization","name":"bluebird bio, Inc.","symbol":"BLUE"},"owners":[{"id":46910,"kind":"person","name":"Paulson Richard A.","position":1,"cik":"0001804460","reported_name":"Paulson Richard A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-03T21:14:16.000Z","date":"2025-05-30","kind":"other","planned":false,"acquired":false,"shares":155,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In connection with the terms of an Agreement and Plan of Merger, dated as of February 21, 2025 (as amended, the \"Merger Agreement\"), by and among the Issuer, Beacon Parent Holdings, L.P. (\"Parent\") and Beacon Merger Sub, Inc., an indirect wholly owned subsidiary of Parent (\"Purchaser\"), Purchaser completed a tender offer for shares of the Issuer's Common Stock. Tendering stockholders were given the option to receive per share consideration of either (x) $3.00 in cash per share, subject to any applicable withholding taxes and without interest thereon, plus one contingent value right (\"CVR\") per share, representing the right to receive one contingent payment of $6.84, in cash, subject to any applicable withholding taxes and without interest thereon, upon achievement of the specified milestone or (y) $5.00 in cash per share, subject to any applicable withholding taxes and without interest thereon (collectively, the \"Offer Price\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(Continued from footnote 1) After completion of the tender offer, Purchaser merged with and into the Issuer (the \"Merger\"), effective as of June 2, 2025 (the \"Effective Time\"), with the Issuer continuing as the surviving entity and a wholly owned subsidiary of Parent."}],"balance_after":1323,"source":{"system":"sec-edgar","filing":"0000950170-25-081108","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804460/000095017025081108/ownership.xml","form_type":"4"}},{"id":1156246,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":46910,"kind":"person","name":"Paulson Richard A.","position":1,"cik":"0001804460","reported_name":"Paulson Richard A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-05-07T21:03:41.000Z","date":"2025-05-06","kind":"sale","planned":false,"acquired":false,"shares":236,"price":7.12,"value":1680.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a durable automatic sale instruction plan adopted by the reporting person on June 10, 2021, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units. The sale does not represent a discretionary trade by the reporting person."}],"balance_after":82503,"source":{"system":"sec-edgar","filing":"0000950170-25-065884","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804460/000095017025065884/ownership.xml","form_type":"4"}},{"id":1176734,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":46910,"kind":"person","name":"Paulson Richard A.","position":1,"cik":"0001804460","reported_name":"Paulson Richard A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-04-07T20:59:22.000Z","date":"2025-04-04","kind":"sale","planned":false,"acquired":false,"shares":245,"price":3.74,"value":916.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a durable automatic sale instruction plan adopted by the reporting person on June 10, 2021, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units. The sale does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $3.74 to $3.86, inclusive. The reporting person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":82739,"source":{"system":"sec-edgar","filing":"0000950170-25-051658","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804460/000095017025051658/ownership.xml","form_type":"4"}},{"id":1219694,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":46910,"kind":"person","name":"Paulson Richard A.","position":1,"cik":"0001804460","reported_name":"Paulson Richard A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-03-06T21:27:06.000Z","date":"2025-03-04","kind":"sale","planned":false,"acquired":false,"shares":11694,"price":6.29,"value":73555.26,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a durable automatic sale instruction plan adopted by the reporting person on June 10, 2021, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units. The sale does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $6.11 to $6.31, inclusive. The reporting person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":82984,"source":{"system":"sec-edgar","filing":"0000950170-25-034736","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804460/000095017025034736/ownership.xml","form_type":"4"}},{"id":1229003,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":46910,"kind":"person","name":"Paulson Richard A.","position":1,"cik":"0001804460","reported_name":"Paulson Richard A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2025-03-04T21:48:40.000Z","date":"2025-02-28","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Amounts reported in this Form 4 reflect the one-for-fifteen reverse stock split effected by the Issuer on February 25, 2025."},{"field":"shares","element":"transactionShares","label":"F2","text":"Amounts reported in this Form 4 reflect the one-for-fifteen reverse stock split effected by the Issuer on February 25, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on February 28, 2025 pursuant to the 2022 Plan. The shares underlying this option vest as to 25% of the shares on February 28, 2026, with the remaining 75% vesting in 36 equal monthly installments thereafter."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Amounts reported in this Form 4 reflect the one-for-fifteen reverse stock split effected by the Issuer on February 25, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amounts reported in this Form 4 reflect the one-for-fifteen reverse stock split effected by the Issuer on February 25, 2025."}],"balance_after":40000,"derivative":{"exercise_price":7.95,"expiration_date":"2035-02-27","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0000950170-25-032297","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1804460/000095017025032297/ownership.xml","form_type":"4"}},{"id":1229002,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":46910,"kind":"person","name":"Paulson Richard A.","position":1,"cik":"0001804460","reported_name":"Paulson Richard A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-03-04T21:48:40.000Z","date":"2025-02-28","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the award of restricted stock units (\"RSUs\") pursuant to the Karyopharm Therapeutics Inc. 2022 Equity Incentive Plan, as amended (the \"2022 Plan\"). RSUs convert into Karyopharm Therapeutics Inc. common stock on a one-for-one basis. The RSUs vest in three equal annual installments beginning February 28, 2026."},{"field":"shares","element":"transactionShares","label":"F2","text":"Amounts reported in this Form 4 reflect the one-for-fifteen reverse stock split effected by the Issuer on February 25, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amounts reported in this Form 4 reflect the one-for-fifteen reverse stock split effected by the Issuer on February 25, 2025."}],"balance_after":94678,"source":{"system":"sec-edgar","filing":"0000950170-25-032297","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804460/000095017025032297/ownership.xml","form_type":"4"}},{"id":1281973,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":46910,"kind":"person","name":"Paulson Richard A.","position":1,"cik":"0001804460","reported_name":"Paulson Richard A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-02-05T21:16:21.000Z","date":"2025-02-04","kind":"sale","planned":false,"acquired":false,"shares":4099,"price":0.65,"value":2664.35,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a durable automatic sale instruction plan adopted by the reporting person on June 10, 2021, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units. The sale does not represent a discretionary trade by the reporting person."}],"balance_after":1120158,"source":{"system":"sec-edgar","filing":"0000950170-25-014491","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804460/000095017025014491/ownership.xml","form_type":"4"}},{"id":1308178,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":46910,"kind":"person","name":"Paulson Richard A.","position":1,"cik":"0001804460","reported_name":"Paulson Richard A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-01-07T21:03:20.000Z","date":"2025-01-06","kind":"sale","planned":false,"acquired":false,"shares":4055,"price":0.783,"value":3175.065,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a durable automatic sale instruction plan adopted by the reporting person on June 10, 2021, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units. The sale does not represent a discretionary trade by the reporting person."}],"balance_after":1124257,"source":{"system":"sec-edgar","filing":"0000950170-25-002819","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804460/000095017025002819/ownership.xml","form_type":"4"}},{"id":1341676,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":46910,"kind":"person","name":"Paulson Richard A.","position":1,"cik":"0001804460","reported_name":"Paulson Richard A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-12-05T21:15:34.000Z","date":"2024-12-04","kind":"sale","planned":false,"acquired":false,"shares":3620,"price":0.81,"value":2932.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a durable automatic sale instruction plan adopted by the reporting person on June 10, 2021, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units. The sale does not represent a discretionary trade by the reporting person."}],"balance_after":1128312,"source":{"system":"sec-edgar","filing":"0000950170-24-133689","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804460/000095017024133689/ownership.xml","form_type":"4"}},{"id":1371495,"issuer":{"id":78923,"kind":"organization","name":"bluebird bio, Inc.","symbol":"BLUE"},"owners":[{"id":46910,"kind":"person","name":"Paulson Richard A.","position":1,"cik":"0001804460","reported_name":"Paulson Richard A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-11-08T21:08:53.000Z","date":"2024-11-06","kind":"grant","planned":false,"acquired":true,"shares":49850,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests 100% on the earlier of November 6, 2025 or the date of the next annual meeting of stockholders."}],"balance_after":49850,"derivative":{"exercise_price":0.44,"expiration_date":"2034-11-06","underlying":"Common Stock","underlying_shares":49850},"source":{"system":"sec-edgar","filing":"0001562180-24-007607","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1804460/000156218024007607/primarydocument.xml","form_type":"4"}},{"id":1371494,"issuer":{"id":78923,"kind":"organization","name":"bluebird bio, Inc.","symbol":"BLUE"},"owners":[{"id":46910,"kind":"person","name":"Paulson Richard A.","position":1,"cik":"0001804460","reported_name":"Paulson Richard A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-11-08T21:08:53.000Z","date":"2024-11-06","kind":"grant","planned":false,"acquired":true,"shares":24900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These restricted stock units for common stock vest 100% on the earlier of November 6, 2025 or the date of the next annual meeting of stockholders."}],"balance_after":29563,"source":{"system":"sec-edgar","filing":"0001562180-24-007607","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804460/000156218024007607/primarydocument.xml","form_type":"4"}},{"id":1374325,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":46910,"kind":"person","name":"Paulson Richard A.","position":1,"cik":"0001804460","reported_name":"Paulson Richard A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-11-06T21:06:00.000Z","date":"2024-11-05","kind":"sale","planned":false,"acquired":false,"shares":3675,"price":0.9106,"value":3346.455,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a durable automatic sale instruction plan adopted by the reporting person on June 10, 2021, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units. The sale does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $0.9101 to $0.9350, inclusive. The reporting person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":1131932,"source":{"system":"sec-edgar","filing":"0000950170-24-122274","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804460/000095017024122274/ownership.xml","form_type":"4"}},{"id":1390184,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":46910,"kind":"person","name":"Paulson Richard A.","position":1,"cik":"0001804460","reported_name":"Paulson Richard A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-10-07T20:44:05.000Z","date":"2024-10-04","kind":"sale","planned":false,"acquired":false,"shares":3607,"price":0.8793,"value":3171.6351,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a durable automatic sale instruction plan adopted by the reporting person on June 10, 2021, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units. The sale does not represent a discretionary trade by the reporting person."}],"balance_after":1135607,"source":{"system":"sec-edgar","filing":"0000950170-24-113263","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804460/000095017024113263/ownership.xml","form_type":"4"}},{"id":1414035,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":46910,"kind":"person","name":"Paulson Richard A.","position":1,"cik":"0001804460","reported_name":"Paulson Richard A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-09-05T20:26:14.000Z","date":"2024-09-04","kind":"sale","planned":false,"acquired":false,"shares":3667,"price":0.7218,"value":2646.8406,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a durable automatic sale instruction plan adopted by the reporting person on June 10, 2021, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units. The sale does not represent a discretionary trade by the reporting person."}],"balance_after":1139214,"source":{"system":"sec-edgar","filing":"0000950170-24-104033","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804460/000095017024104033/ownership.xml","form_type":"4"}},{"id":1437886,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":46910,"kind":"person","name":"Paulson Richard A.","position":1,"cik":"0001804460","reported_name":"Paulson Richard A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-08-08T20:31:18.000Z","date":"2024-08-06","kind":"sale","planned":false,"acquired":false,"shares":3608,"price":0.9299,"value":3355.0792,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a durable automatic sale instruction plan adopted by the reporting person on June 10, 2021, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units. The sale does not represent a discretionary trade by the reporting person."}],"balance_after":1142881,"source":{"system":"sec-edgar","filing":"0000950170-24-094087","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804460/000095017024094087/ownership.xml","form_type":"4"}},{"id":1457622,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":46910,"kind":"person","name":"Paulson Richard A.","position":1,"cik":"0001804460","reported_name":"Paulson Richard A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-07-09T20:15:46.000Z","date":"2024-07-05","kind":"sale","planned":false,"acquired":false,"shares":3616,"price":0.851,"value":3077.216,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a durable automatic sale instruction plan adopted by the reporting person on June 10, 2021, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units. The sale does not represent a discretionary trade by the reporting person."}],"balance_after":1146489,"source":{"system":"sec-edgar","filing":"0000950170-24-082417","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804460/000095017024082417/ownership.xml","form_type":"4"}},{"id":1488527,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":46910,"kind":"person","name":"Paulson Richard A.","position":1,"cik":"0001804460","reported_name":"Paulson Richard A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-06-06T20:02:21.000Z","date":"2024-06-04","kind":"sale","planned":false,"acquired":false,"shares":3592,"price":0.99,"value":3556.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a durable automatic sale instruction plan adopted by the reporting person on June 10, 2021, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units. The sale does not represent a discretionary trade by the reporting person."}],"balance_after":1150105,"source":{"system":"sec-edgar","filing":"0000950170-24-069856","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804460/000095017024069856/ownership.xml","form_type":"4"}},{"id":1524834,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":46910,"kind":"person","name":"Paulson Richard A.","position":1,"cik":"0001804460","reported_name":"Paulson Richard A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-05-07T20:56:19.000Z","date":"2024-05-06","kind":"sale","planned":false,"acquired":false,"shares":3576,"price":1.13,"value":4040.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a durable automatic sale instruction plan adopted by the reporting person on June 10, 2021, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units. The sale does not represent a discretionary trade by the reporting person."}],"balance_after":1153697,"source":{"system":"sec-edgar","filing":"0000950170-24-054686","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804460/000095017024054686/ownership.xml","form_type":"4"}},{"id":1546820,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":46910,"kind":"person","name":"Paulson Richard A.","position":1,"cik":"0001804460","reported_name":"Paulson Richard A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-04-05T21:20:02.000Z","date":"2024-04-04","kind":"sale","planned":false,"acquired":false,"shares":3563,"price":1.29,"value":4596.27,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a durable automatic sale instruction plan adopted by the reporting person on June 10, 2021, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units. The sale does not represent a discretionary trade by the reporting person."}],"balance_after":1157273,"source":{"system":"sec-edgar","filing":"0000950170-24-042350","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804460/000095017024042350/ownership.xml","form_type":"4"}},{"id":1591914,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":46910,"kind":"person","name":"Paulson Richard A.","position":1,"cik":"0001804460","reported_name":"Paulson Richard A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-03-06T21:14:01.000Z","date":"2024-03-05","kind":"sale","planned":false,"acquired":false,"shares":3573,"price":1.3,"value":4644.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a durable automatic sale instruction plan adopted by the reporting person on June 10, 2021, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units. The sale does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $1.28 to $1.30, inclusive. The reporting person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":1160836,"source":{"system":"sec-edgar","filing":"0000950170-24-027153","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804460/000095017024027153/ownership.xml","form_type":"4"}},{"id":1603391,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":46910,"kind":"person","name":"Paulson Richard A.","position":1,"cik":"0001804460","reported_name":"Paulson Richard A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common","published_at":"2024-03-05T00:36:27.000Z","date":"2024-03-01","kind":"sale","planned":false,"acquired":false,"shares":19374,"price":1.2,"value":23248.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"This transaction was effected pursuant to a durable automatic sale instruction plan adopted by the reporting person on June 10, 2021, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of performance-based restricted stock units. The sale does not represent a discretionary trade by the reporting person."}],"balance_after":1164409,"source":{"system":"sec-edgar","filing":"0000950170-24-025188","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1804460/000095017024025188/ownership.xml","form_type":"4"}},{"id":1603390,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":46910,"kind":"person","name":"Paulson Richard A.","position":1,"cik":"0001804460","reported_name":"Paulson Richard A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common","published_at":"2024-03-05T00:36:27.000Z","date":"2024-02-29","kind":"sale","planned":false,"acquired":false,"shares":80470,"price":1.17,"value":94149.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a durable automatic sale instruction plan adopted by the reporting person on June 10, 2021, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units. The sale does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $1.12 to $1.18, inclusive. The reporting person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":1183783,"source":{"system":"sec-edgar","filing":"0000950170-24-025188","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804460/000095017024025188/ownership.xml","form_type":"4"}},{"id":1610125,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":46910,"kind":"person","name":"Paulson Richard A.","position":1,"cik":"0001804460","reported_name":"Paulson Richard A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-02-29T22:34:09.000Z","date":"2024-02-28","kind":"grant","planned":false,"acquired":true,"shares":442800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the award of restricted stock units (\"RSUs\") pursuant to the Karyopharm Therapeutics Inc. 2022 Equity Incentive Plan, as amended. RSUs convert into Karyopharm Therapeutics Inc. common stock on a one-for-one basis. The RSUs vest in three equal annual installments beginning February 28, 2025."}],"balance_after":1264253,"source":{"system":"sec-edgar","filing":"0000950170-24-023281","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804460/000095017024023281/ownership.xml","form_type":"4"}},{"id":1653566,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":46910,"kind":"person","name":"Paulson Richard A.","position":1,"cik":"0001804460","reported_name":"Paulson Richard A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-02-08T21:34:08.000Z","date":"2024-02-06","kind":"sale","planned":false,"acquired":false,"shares":4012,"price":1.5865,"value":6365.038,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a durable automatic sale instruction plan adopted by the reporting person on June 10, 2021, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units. The sale does not represent a discretionary trade by the reporting person."}],"balance_after":821453,"source":{"system":"sec-edgar","filing":"0000950170-24-012824","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804460/000095017024012824/ownership.xml","form_type":"4"}},{"id":1671040,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":46910,"kind":"person","name":"Paulson Richard A.","position":1,"cik":"0001804460","reported_name":"Paulson Richard A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-01-25T23:43:10.000Z","date":"2024-01-24","kind":"grant","planned":false,"acquired":true,"shares":42000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of the issuer's common stock underlying performance-based restricted stock units (\"PSUs\") granted in February 2023 that have been earned based on the level of achievement of a certain clinical milestone, as certified by the issuer's compensation committee on January 24, 2024. Each earned PSU represents the contingent right to receive one share of the issuer's common stock upon vesting. The earned PSUs will vest on February 28, 2024, the first anniversary of the grant date, subject to continued employment through such vesting date."}],"balance_after":825465,"source":{"system":"sec-edgar","filing":"0000950170-24-007583","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804460/000095017024007583/ownership.xml","form_type":"4"}},{"id":1684316,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":46910,"kind":"person","name":"Paulson Richard A.","position":1,"cik":"0001804460","reported_name":"Paulson Richard A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-01-09T02:00:39.000Z","date":"2024-01-04","kind":"sale","planned":false,"acquired":false,"shares":4114,"price":0.82,"value":3373.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a durable automatic sale instruction plan adopted by the reporting person on June 10, 2021, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units. The sale does not represent a discretionary trade by the reporting person."}],"balance_after":783465,"source":{"system":"sec-edgar","filing":"0000950170-24-003177","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804460/000095017024003177/ownership.xml","form_type":"4"}},{"id":1721914,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":46910,"kind":"person","name":"Paulson Richard A.","position":1,"cik":"0001804460","reported_name":"Paulson Richard A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-12-05T22:03:22.000Z","date":"2023-12-04","kind":"sale","planned":false,"acquired":false,"shares":3622,"price":0.79,"value":2861.38,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a durable automatic sale instruction plan adopted by the reporting person on June 10, 2021, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units.  The sale does not represent a discretionary trade by the reporting person."}],"balance_after":787579,"source":{"system":"sec-edgar","filing":"0001209191-23-057465","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804460/000120919123057465/doc4.xml","form_type":"4"}},{"id":1747704,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":46910,"kind":"person","name":"Paulson Richard A.","position":1,"cik":"0001804460","reported_name":"Paulson Richard A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-11-07T22:32:47.000Z","date":"2023-11-06","kind":"sale","planned":false,"acquired":false,"shares":3606,"price":0.9203,"value":3318.6018,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a durable automatic sale instruction plan adopted by the reporting person on June 10, 2021, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units.  The sale does not represent a discretionary trade by the reporting person."}],"balance_after":791201,"source":{"system":"sec-edgar","filing":"0001209191-23-054626","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804460/000120919123054626/doc4.xml","form_type":"4"}},{"id":1764360,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":46910,"kind":"person","name":"Paulson Richard A.","position":1,"cik":"0001804460","reported_name":"Paulson Richard A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-10-05T20:46:21.000Z","date":"2023-10-04","kind":"sale","planned":false,"acquired":false,"shares":3589,"price":1.27,"value":4558.03,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a durable automatic sale instruction plan adopted by the reporting person on June 10, 2021, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units.  The sale does not represent a discretionary trade by the reporting person."}],"balance_after":794807,"source":{"system":"sec-edgar","filing":"0001209191-23-052215","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804460/000120919123052215/doc4.xml","form_type":"4"}},{"id":1787348,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":46910,"kind":"person","name":"Paulson Richard A.","position":1,"cik":"0001804460","reported_name":"Paulson Richard A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-09-06T20:06:34.000Z","date":"2023-09-05","kind":"sale","planned":false,"acquired":false,"shares":64,"price":1.32,"value":84.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a durable automatic sale instruction plan adopted by the reporting person on June 10, 2021, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units. The sale does not represent a discretionary trade by the reporting person."}],"balance_after":798396,"source":{"system":"sec-edgar","filing":"0000950170-23-046721","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1804460/000095017023046721/ownership.xml","form_type":"4"}},{"id":1787347,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":46910,"kind":"person","name":"Paulson Richard A.","position":1,"cik":"0001804460","reported_name":"Paulson Richard A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-09-06T20:06:34.000Z","date":"2023-09-05","kind":"sale","planned":false,"acquired":false,"shares":3558,"price":1.33,"value":4732.14,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a durable automatic sale instruction plan adopted by the reporting person on June 10, 2021, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units. The sale does not represent a discretionary trade by the reporting person."}],"balance_after":798460,"source":{"system":"sec-edgar","filing":"0000950170-23-046721","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804460/000095017023046721/ownership.xml","form_type":"4"}},{"id":1813005,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":46910,"kind":"person","name":"Paulson Richard A.","position":1,"cik":"0001804460","reported_name":"Paulson Richard A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-08-08T21:02:45.000Z","date":"2023-08-07","kind":"sale","planned":true,"acquired":false,"shares":3722,"price":1.72,"value":6401.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a durable automatic sale instruction plan adopted by the reporting person on June 10, 2021, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units.  The sale does not represent a discretionary trade by the reporting person."}],"balance_after":802018,"source":{"system":"sec-edgar","filing":"0001209191-23-045045","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804460/000120919123045045/doc4.xml","form_type":"4"}},{"id":1834008,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":46910,"kind":"person","name":"Paulson Richard A.","position":1,"cik":"0001804460","reported_name":"Paulson Richard A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-07-06T21:36:04.000Z","date":"2023-07-05","kind":"sale","planned":true,"acquired":false,"shares":3538,"price":1.72,"value":6085.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a durable automatic sale instruction plan adopted by the reporting person on June 10, 2021, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units.  The sale does not represent a discretionary trade by the reporting person."}],"balance_after":805740,"source":{"system":"sec-edgar","filing":"0001209191-23-041635","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804460/000120919123041635/doc4.xml","form_type":"4"}},{"id":1864023,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":46910,"kind":"person","name":"Paulson Richard A.","position":1,"cik":"0001804460","reported_name":"Paulson Richard A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-06-07T20:11:09.000Z","date":"2023-06-05","kind":"sale","planned":true,"acquired":false,"shares":3536,"price":2.2404,"value":7922.0544,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a durable automatic sale instruction plan adopted by the reporting person on June 10, 2021, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units.  The sale does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $2.24 to $2.325, inclusive. The reporting person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":809278,"source":{"system":"sec-edgar","filing":"0001209191-23-035057","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804460/000120919123035057/doc4.xml","form_type":"4"}},{"id":1902937,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":46910,"kind":"person","name":"Paulson Richard A.","position":1,"cik":"0001804460","reported_name":"Paulson Richard A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-05-05T21:06:22.000Z","date":"2023-05-04","kind":"sale","planned":true,"acquired":false,"shares":3805,"price":3.3516,"value":12752.838,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a durable automatic sale instruction plan adopted by the reporting person on June 10, 2021, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units. The sale does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $3.35 to $3.37, inclusive. The reporting person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":812814,"source":{"system":"sec-edgar","filing":"0000899243-23-012353","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804460/000089924323012353/doc4.xml","form_type":"4"}},{"id":1925277,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":46910,"kind":"person","name":"Paulson Richard A.","position":1,"cik":"0001804460","reported_name":"Paulson Richard A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-04-05T21:06:07.000Z","date":"2023-04-04","kind":"sale","planned":true,"acquired":false,"shares":3497,"price":3.97,"value":13883.09,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a durable automatic sale instruction plan adopted by the reporting person on June 10, 2021, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units.  The sale does not represent a discretionary trade by the reporting person."}],"balance_after":816619,"source":{"system":"sec-edgar","filing":"0001209191-23-023378","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804460/000120919123023378/doc4.xml","form_type":"4"}},{"id":1925276,"issuer":{"id":78923,"kind":"organization","name":"bluebird bio, Inc.","symbol":"BLUE"},"owners":[{"id":46910,"kind":"person","name":"Paulson Richard A.","position":1,"cik":"0001804460","reported_name":"Paulson Richard A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2023-04-05T20:07:56.000Z","date":"2023-04-03","kind":"grant","planned":false,"acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests ratably over three years in annual installments commencing on April 3, 2023."}],"balance_after":7500,"derivative":{"exercise_price":3.3,"expiration_date":"2033-04-03","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001562180-23-003435","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1804460/000156218023003435/primarydocument.xml","form_type":"4"}},{"id":1925275,"issuer":{"id":78923,"kind":"organization","name":"bluebird bio, Inc.","symbol":"BLUE"},"owners":[{"id":46910,"kind":"person","name":"Paulson Richard A.","position":1,"cik":"0001804460","reported_name":"Paulson Richard A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-04-05T20:07:56.000Z","date":"2023-04-03","kind":"grant","planned":false,"acquired":true,"shares":4663,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units for common stock vest ratably over three years in annual installments commencing on April 3, 2023."}],"balance_after":4663,"source":{"system":"sec-edgar","filing":"0001562180-23-003435","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804460/000156218023003435/primarydocument.xml","form_type":"4"}},{"id":1966208,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":46910,"kind":"person","name":"Paulson Richard A.","position":1,"cik":"0001804460","reported_name":"Paulson Richard A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-03-07T21:06:05.000Z","date":"2023-03-06","kind":"sale","acquired":false,"shares":3506,"price":3.16,"value":11078.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units and does not represent a discretionary trade by the reporting person."}],"balance_after":820116,"source":{"system":"sec-edgar","filing":"0001209191-23-016700","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804460/000120919123016700/doc4.xml","form_type":"4"}},{"id":1979795,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":46910,"kind":"person","name":"Paulson Richard A.","position":1,"cik":"0001804460","reported_name":"Paulson Richard A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-03-02T22:28:40.000Z","date":"2023-03-01","kind":"sale","acquired":false,"shares":33033,"price":3.0292,"value":100063.5636,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units and does not represent a discretionary trade by the reporting person."}],"balance_after":823622,"source":{"system":"sec-edgar","filing":"0001209191-23-014838","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1804460/000120919123014838/doc4.xml","form_type":"4"}},{"id":1979794,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":46910,"kind":"person","name":"Paulson Richard A.","position":1,"cik":"0001804460","reported_name":"Paulson Richard A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-03-02T22:28:40.000Z","date":"2023-02-28","kind":"grant","acquired":true,"shares":252000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the award of restricted stock units (\"RSUs\") pursuant to the Karyopharm Therapeutics Inc. 2022 Equity Incentive Plan. RSUs convert into Karyopharm Therapeutics Inc. common stock on a one-for-one basis. The RSUs vest in three equal annual installments beginning February 28, 2024."}],"balance_after":856655,"source":{"system":"sec-edgar","filing":"0001209191-23-014838","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804460/000120919123014838/doc4.xml","form_type":"4"}},{"id":2026603,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":46910,"kind":"person","name":"Paulson Richard A.","position":1,"cik":"0001804460","reported_name":"Paulson Richard A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-02-08T21:09:00.000Z","date":"2023-02-06","kind":"sale","acquired":false,"shares":3950,"price":3.4,"value":13430.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units and does not represent a discretionary trade by the reporting person."}],"balance_after":604655,"source":{"system":"sec-edgar","filing":"0001209191-23-007772","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804460/000120919123007772/doc4.xml","form_type":"4"}},{"id":2062970,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":46910,"kind":"person","name":"Paulson Richard A.","position":1,"cik":"0001804460","reported_name":"Paulson Richard A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-01-05T23:16:12.000Z","date":"2023-01-04","kind":"sale","acquired":false,"shares":3922,"price":3.27,"value":12824.94,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units and does not represent a discretionary trade by the reporting person."}],"balance_after":608605,"source":{"system":"sec-edgar","filing":"0001209191-23-002052","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804460/000120919123002052/doc4.xml","form_type":"4"}},{"id":2094596,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":46910,"kind":"person","name":"Paulson Richard A.","position":1,"cik":"0001804460","reported_name":"Paulson Richard A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-12-06T22:00:35.000Z","date":"2022-12-05","kind":"sale","acquired":false,"shares":3490,"price":5.17,"value":18043.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units and does not represent a discretionary trade by the reporting person."}],"balance_after":612527,"source":{"system":"sec-edgar","filing":"0001209191-22-060041","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804460/000120919122060041/doc4.xml","form_type":"4"}},{"id":2122350,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":46910,"kind":"person","name":"Paulson Richard A.","position":1,"cik":"0001804460","reported_name":"Paulson Richard A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-11-08T23:19:48.000Z","date":"2022-11-04","kind":"sale","acquired":false,"shares":3493,"price":4.54,"value":15858.22,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units and does not represent a discretionary trade by the reporting person."}],"balance_after":616017,"source":{"system":"sec-edgar","filing":"0001209191-22-056152","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804460/000120919122056152/doc4.xml","form_type":"4"}},{"id":2142313,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":46910,"kind":"person","name":"Paulson Richard A.","position":1,"cik":"0001804460","reported_name":"Paulson Richard A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-10-05T20:12:33.000Z","date":"2022-10-04","kind":"sale","acquired":false,"shares":3488,"price":5.87,"value":20474.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units and does not represent a discretionary trade by the reporting person."}],"balance_after":619510,"source":{"system":"sec-edgar","filing":"0001209191-22-052726","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804460/000120919122052726/doc4.xml","form_type":"4"}},{"id":2162365,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":46910,"kind":"person","name":"Paulson Richard A.","position":1,"cik":"0001804460","reported_name":"Paulson Richard A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-09-09T12:17:44.000Z","date":"2022-09-08","kind":"sale","acquired":false,"shares":3463,"price":5.23,"value":18111.49,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units and does not represent a discretionary trade by the reporting person."}],"balance_after":622998,"source":{"system":"sec-edgar","filing":"0001209191-22-049255","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1804460/000120919122049255/doc4.xml","form_type":"4"}},{"id":2162364,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":46910,"kind":"person","name":"Paulson Richard A.","position":1,"cik":"0001804460","reported_name":"Paulson Richard A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-09-09T12:17:44.000Z","date":"2022-09-08","kind":"sale","acquired":false,"shares":16,"price":5.2563,"value":84.1008,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units and does not represent a discretionary trade by the reporting person."}],"balance_after":626461,"source":{"system":"sec-edgar","filing":"0001209191-22-049255","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804460/000120919122049255/doc4.xml","form_type":"4"}},{"id":2193393,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":46910,"kind":"person","name":"Paulson Richard A.","position":1,"cik":"0001804460","reported_name":"Paulson Richard A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-08-05T20:08:52.000Z","date":"2022-08-04","kind":"sale","acquired":false,"shares":2314,"price":4.48,"value":10366.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units and does not represent a discretionary trade by the reporting person."}],"balance_after":626477,"source":{"system":"sec-edgar","filing":"0001209191-22-044561","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804460/000120919122044561/doc4.xml","form_type":"4"}},{"id":2209242,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":46910,"kind":"person","name":"Paulson Richard A.","position":1,"cik":"0001804460","reported_name":"Paulson Richard A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-07-11T20:18:55.000Z","date":"2022-07-08","kind":"sale","acquired":false,"shares":2115,"price":5.1762,"value":10947.663,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units and does not represent a discretionary trade by the reporting person."}],"balance_after":628791,"source":{"system":"sec-edgar","filing":"0001209191-22-041774","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804460/000120919122041774/doc4.xml","form_type":"4"}},{"id":2239179,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":46910,"kind":"person","name":"Paulson Richard A.","position":1,"cik":"0001804460","reported_name":"Paulson Richard A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-06-08T20:23:11.000Z","date":"2022-06-07","kind":"sale","acquired":false,"shares":2542,"price":5.7602,"value":14642.4284,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units and does not represent a discretionary trade by the reporting person."}],"balance_after":630906,"source":{"system":"sec-edgar","filing":"0000899243-22-021477","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804460/000089924322021477/doc4.xml","form_type":"4"}},{"id":2280926,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":46910,"kind":"person","name":"Paulson Richard A.","position":1,"cik":"0001804460","reported_name":"Paulson Richard A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-05-05T20:08:07.000Z","date":"2022-05-04","kind":"sale","acquired":false,"shares":27869,"price":6.2272,"value":173545.8368,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units and does not represent a discretionary trade by the reporting person."}],"balance_after":633448,"source":{"system":"sec-edgar","filing":"0001209191-22-027344","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1804460/000120919122027344/doc4.xml","form_type":"4"}},{"id":2280925,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":46910,"kind":"person","name":"Paulson Richard A.","position":1,"cik":"0001804460","reported_name":"Paulson Richard A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-05-05T20:08:07.000Z","date":"2022-05-04","kind":"sale","acquired":false,"shares":633,"price":6.2614,"value":3963.4662,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units and does not represent a discretionary trade by the reporting person."}],"balance_after":661317,"source":{"system":"sec-edgar","filing":"0001209191-22-027344","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804460/000120919122027344/doc4.xml","form_type":"4"}},{"id":2361104,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":46910,"kind":"person","name":"Paulson Richard A.","position":1,"cik":"0001804460","reported_name":"Paulson Richard A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2022-03-02T20:14:16.000Z","date":"2022-02-28","kind":"grant","acquired":true,"shares":360000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on February 28, 2022 pursuant to the Plan.  The shares underlying this option vest as to 25% of the shares on February 28, 2023, with the remaining 75% vesting in 36 equal monthly installments thereafter."}],"balance_after":360000,"derivative":{"exercise_price":10.33,"expiration_date":"2032-02-27","underlying":"Common Stock","underlying_shares":360000},"source":{"system":"sec-edgar","filing":"0001209191-22-014619","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1804460/000120919122014619/doc4.xml","form_type":"4"}},{"id":2361103,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":46910,"kind":"person","name":"Paulson Richard A.","position":1,"cik":"0001804460","reported_name":"Paulson Richard A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-03-02T20:14:16.000Z","date":"2022-02-28","kind":"grant","acquired":true,"shares":288750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the award of restricted stock units (\"RSUs\") pursuant to the Karyopharm Therapeutics Inc. 2013 Stock Incentive Plan (the \"Plan\").  RSUs convert into Karyopharm Therapeutics Inc. common stock on a one-for-one basis.  The RSUs vest in four equal annual installments beginning February 28, 2023."}],"balance_after":661950,"source":{"system":"sec-edgar","filing":"0001209191-22-014619","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804460/000120919122014619/doc4.xml","form_type":"4"}},{"id":2730417,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":46910,"kind":"person","name":"Paulson Richard A.","position":1,"cik":"0001804460","reported_name":"Paulson Richard A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2021-05-05T01:06:20.000Z","date":"2021-05-03","kind":"grant","acquired":true,"shares":559800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on May 3, 2021 pursuant to the Plan.  The shares underlying this option vest as to 25% of the shares on May 3, 2022, with the remaining 75% vesting in 36 equal monthly installments thereafter."}],"balance_after":559800,"derivative":{"exercise_price":9.44,"expiration_date":"2031-05-02","underlying":"Common Stock","underlying_shares":559800},"source":{"system":"sec-edgar","filing":"0001209191-21-030166","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1804460/000120919121030166/doc4.xml","form_type":"4"}},{"id":2730416,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":46910,"kind":"person","name":"Paulson Richard A.","position":1,"cik":"0001804460","reported_name":"Paulson Richard A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-05-05T01:06:20.000Z","date":"2021-05-03","kind":"grant","acquired":true,"shares":373200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the award of restricted stock units (\"RSUs\") pursuant to the Karyopharm Therapeutics Inc. 2013 Stock Incentive Plan (the \"Plan\"). RSUs convert into Karyopharm Therapeutics Inc. common stock on a one-for-one basis. The RSUs vest as to 25% of the shares on May 3, 2022, with the remaining 75% vesting in 36 equal monthly installments thereafter."}],"balance_after":373200,"source":{"system":"sec-edgar","filing":"0001209191-21-030166","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804460/000120919121030166/doc4.xml","form_type":"4"}},{"id":3135347,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":46910,"kind":"person","name":"Paulson Richard A.","position":1,"cik":"0001804460","reported_name":"Paulson Richard A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Nonstatutory Stock Option (right to buy)","published_at":"2020-05-26T20:25:24.000Z","date":"2020-05-21","kind":"grant","acquired":true,"shares":16400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests as to 100% of the underlying shares on May 21, 2021, provided that the reporting person continues to serve as a director of the issuer through such date."}],"balance_after":16400,"derivative":{"exercise_price":19.11,"expiration_date":"2030-05-20","underlying":"Common Stock","underlying_shares":16400},"source":{"system":"sec-edgar","filing":"0001209191-20-032013","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804460/000120919120032013/doc4.xml","form_type":"4"}},{"id":3220752,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":46910,"kind":"person","name":"Paulson Richard A.","position":1,"cik":"0001804460","reported_name":"Paulson Richard A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Nonstatutory Stock Option (right to buy)","published_at":"2020-03-09T21:11:16.000Z","date":"2020-03-05","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on March 5, 2020. The shares underlying this option vest as to one-third (1/3) of the shares on March 5, 2021 and as to the remaining two-thirds (2/3) of the shares in 24 equal monthly installments thereafter."}],"balance_after":50000,"derivative":{"exercise_price":26.12,"expiration_date":"2030-03-04","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001209191-20-017361","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804460/000120919120017361/doc4.xml","form_type":"4"}}]}